Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Second Affiliated Hospital, Zhejiang University, School of Medicine
With
Huzhou Central Hospital
Ningbo Medical Center Lihuili Hospital
Hangzhou Hospital of Traditional Chinese Medicine
The first people Hospital of Linhai
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, aged between 18 and 75;
According to the diagnostic criteria of the International Classification of Headache Disorders (ICHD-III), the diagnosis is episodic migraine with or without aura or probable migraine with or without aura;
The duration of the illness is at least 12 months;
The age of onset of the first migraine is less than 50 years old;
During the screening period of 4 weeks, there were 2-8 episodes of headache, with moderate or severe pain intensity;
Before screening, the subjects should provide their previous medical records as much as possible;
Participants can distinguish migraines from other conditions, including tension-type headaches and cluster headaches
Understand and adhere to the research procedures and methods, voluntarily participate in this trial, and sign the informed consent form in writing;
You may not be if
Pregnant and lactating women;
Suffering from arrhythmia or other heart diseases (such as ischemic heart disease, coronary artery spasm, myocardial infarction, acute coronary syndrome, percutaneous coronary intervention, angina pectoris);
Have undergone surgery within the past 6 months;
Recent stroke or transient ischemic attack;
Equipped with a pacemaker;
History of previous seizures;
Metal implants in the head;
Patients with clinical evidence of brain damage;
Chronic pain associated with other diseases;
Use antipsychotic drugs;
Those who are intolerant to neuroregulators;
Employees of the research center or their immediate family members.
There is a condition or anomaly that the investigator believes may affect patient safety or data quality
Clareo Health | Multicenter, Double-blind, and Randomized Controlled Trial of Ultra-Distal TENS Device for Migraine Treatment
